Localization of 67 exons on a YAC contig spanning 1.5 Mb around the multidrug resistance gene region of human chromosome 7q21.1. 1998

K Torigoe, and T Harada, and H Kusaba, and T Uchiumi, and K Kohno, and E D Green, and S W Scherer, and L C Tsui, and D Schlessinger, and M Kuwano, and M Wada
Department of Biochemistry, Kyushu University School of Medicine, Fukuoka, Japan.

A contig of 21 nonchimeric yeast artificial chromosomes (YACs) was previously assembled across 1.5 Mb of the multidrug resistance (MDR) gene (PGY1 and PGY3) region of human chromosome 7q21.1. This region of the human genome has now been subjected to exon amplification to detect the presence of additional genes. Exon trapping was performed directly on the YACs. Sixty-seven gene fragments were isolated and characterized by sequence analysis and comparison with public databases. The localization of these exons in the 1.5-Mb region was determined by hybridization to YAC clones, and they were localized in 11 subregions of YAC contigs. The exon collection includes 21 exons that were identical to known cDNA sequences of PGY1, PGY3, sorcin (SRI), the cDNA similar to the delta subunit of the human amiloride-sensitive Na- channel (SCNED), and 4 cDNAs with unknown function; 43 exons that showed homology/similarity to known cDNA sequences of mouse DMP1, rat COT, mouse and human NADHD, human MDC, 3 cDNAs encoding possible membrane proteins, and 21 other cDNAs; and 3 exons that shared no homology/similarity with any sequence in public databases. The nucleotide sequences of all the PGY1 and PGY3 exons were identical to the corresponding cDNA sequences previously determined, and these exons were localized to the expected positions on the appropriate YAC clones. No other member of the MDR gene family thus appeared to be present in the 1.5-Mb region. The integrated physical and exon maps should prove valuable for both fine mapping and determination of a complete gene map of this segment of the genome.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009245 NADH Dehydrogenase A flavoprotein and iron sulfur-containing oxidoreductase that catalyzes the oxidation of NADH to NAD. In eukaryotes the enzyme can be found as a component of mitochondrial electron transport complex I. Under experimental conditions the enzyme can use CYTOCHROME C GROUP as the reducing cofactor. The enzyme was formerly listed as EC 1.6.2.1. NADH Cytochrome c Reductase,Diaphorase (NADH Dehydrogenase),NADH (Acceptor) Oxidoreductase,NADH Cytochrome c Oxidoreductase,Dehydrogenase, NADH
D002333 Carnitine Acyltransferases Acyltransferases in the inner mitochondrial membrane that catalyze the reversible transfer of acyl groups from acyl-CoA to L-carnitine and thereby mediate the transport of activated fatty acids through that membrane. EC 2.3.1. Acylcarnitine Translocase,Carnitine Translocase,Carnitine-Acetylcarnitine Translocase,Carnitine-Acylcarnitine Translocase,Acyltransferases, Carnitine,Carnitine Acetylcarnitine Translocase,Carnitine Acylcarnitine Translocase,Translocase, Acylcarnitine,Translocase, Carnitine,Translocase, Carnitine-Acetylcarnitine,Translocase, Carnitine-Acylcarnitine
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002897 Chromosomes, Human, Pair 7 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 7
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

K Torigoe, and T Harada, and H Kusaba, and T Uchiumi, and K Kohno, and E D Green, and S W Scherer, and L C Tsui, and D Schlessinger, and M Kuwano, and M Wada
October 1995, Genome research,
K Torigoe, and T Harada, and H Kusaba, and T Uchiumi, and K Kohno, and E D Green, and S W Scherer, and L C Tsui, and D Schlessinger, and M Kuwano, and M Wada
December 1995, Genomics,
K Torigoe, and T Harada, and H Kusaba, and T Uchiumi, and K Kohno, and E D Green, and S W Scherer, and L C Tsui, and D Schlessinger, and M Kuwano, and M Wada
October 1995, Genomics,
K Torigoe, and T Harada, and H Kusaba, and T Uchiumi, and K Kohno, and E D Green, and S W Scherer, and L C Tsui, and D Schlessinger, and M Kuwano, and M Wada
October 1992, Human molecular genetics,
K Torigoe, and T Harada, and H Kusaba, and T Uchiumi, and K Kohno, and E D Green, and S W Scherer, and L C Tsui, and D Schlessinger, and M Kuwano, and M Wada
May 1994, Genomics,
K Torigoe, and T Harada, and H Kusaba, and T Uchiumi, and K Kohno, and E D Green, and S W Scherer, and L C Tsui, and D Schlessinger, and M Kuwano, and M Wada
January 1993, European journal of human genetics : EJHG,
K Torigoe, and T Harada, and H Kusaba, and T Uchiumi, and K Kohno, and E D Green, and S W Scherer, and L C Tsui, and D Schlessinger, and M Kuwano, and M Wada
January 1996, Cytogenetics and cell genetics,
K Torigoe, and T Harada, and H Kusaba, and T Uchiumi, and K Kohno, and E D Green, and S W Scherer, and L C Tsui, and D Schlessinger, and M Kuwano, and M Wada
May 1994, Genomics,
K Torigoe, and T Harada, and H Kusaba, and T Uchiumi, and K Kohno, and E D Green, and S W Scherer, and L C Tsui, and D Schlessinger, and M Kuwano, and M Wada
April 1999, Genomics,
K Torigoe, and T Harada, and H Kusaba, and T Uchiumi, and K Kohno, and E D Green, and S W Scherer, and L C Tsui, and D Schlessinger, and M Kuwano, and M Wada
February 1994, Genomics,
Copied contents to your clipboard!